Q3 2025 Earnings Call October 24, 2025 8:30 AM EDTCompany ParticipantsThomas Larsen - Head of Investor RelationsPaul Hudson - CEO ...

Pociredir Phase 1b PIONEER Trial Data in Sickle Cell Disease to be Presented and Published, Including 12 mg and 20 mg Cohorts ―― Live and ...

Thousands of Californians live with sickle cell disease, a painful blood disorder. But new treatments, including a promising form of gene therapy, are offering hope to ...

Most individuals living with sickle cell disease who presented to the emergency department with a pain crisis, known as vaso-occlusive crisis (VOC), were not triaged appropriately according to ...

Sickle cell disease, a genetic blood disorder, disproportionately affects Black individuals, with one in 365 Black babies born with it in the U.S. New, high-cost gene therapies offer potential cures ...

For years, Adesayo Talabi, known online as Simply Sayo, thought her sister Elizabeth's medication and frequent check-ups were just part of everyday life, not the warning signs of a life-threatening ...

The singer also lamented the lifelong medication the condition subjects him to.Nigerian musician Adekunle Kosoko, popularly known as Adekunle Gold, has revealed his ongoing struggles with sickle cell ...

Most patients living with sickle cell disease who went to the emergency department of a U.S. hospital with a severe pain crisis were not triaged properly and faced long delays. Those triaged with a ...

Fear, anxiety, stress, and burnout can all happen to parents of children with sickle cell disease, writes columnist.

Reaffirms full-year 2025 Revenue guidance of $61.0 to $64.0 billion. Raises and narrows Adjusted (2) diluted EPS guidance (1) ...